Nicolet Bankshares’s Soleno Therapeutics SLNO Stock Holding History

Nicolet Bankshares’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-156,766	Closed	-$5.25M	–	644
2026 Q1	$5.25M	Buy	+156,766	New	+$6.15M	0.19%	92

Nicolet Bankshares's SLNO Position: Q2 2026 in Review

Nicolet Bankshares sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 156,766 shares — an estimated $5.25M sold.

Nicolet Bankshares first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $5.25M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Nicolet Bankshares reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Nicolet Bankshares sold 156,766 Soleno Therapeutics shares in Q2 2026, an estimated $5.25M.
Nicolet Bankshares first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Nicolet Bankshares's Soleno Therapeutics position peaked at $5.25M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.